Comment · Wed, December 16, 2015
The forefront for 2016 - New compounds on MYASD's mind
Original post in this thread
srubek · 8 points
Now that things are starting to settle down from the chaos that was quarter 4 of 2015, and since today's newsletter said the site will be revamped for 2016, can we expect any new compounds/preparations, as well?
Give us a glimpse, /u/misteryouaresodumb !
- - - - - - - - - - - -
Personally, I'm interested in NA-Selank-Amidate as a premade nasal spray (I find best results with their premade sprays, rather than making them myself) and further semax peptide modifications, along with, of course, P21 in a nasal spray preparation.
- - - - - - - - - - - - -
What's on the forefront, Paul?
Much love, as always!
What they were answering
Direct reply to the original post — see the thread post above.
u/MisterYouAreSoDumb
We gone through some shit these past few months, that's for sure. If we had not had all these issues, we would have had at least 15 more products up by now; some of them really innovative. However, this has forced us to reevaluate operations, and forced me to make some difficult decisions regarding the direction of the company. That's fine. The only constant in life is change. How we persevere through challenges is what defines us. I've moved past the frustration and discouragement of the recent occurrences, and am now devoting my energy to the future. This is getting me excited for things to come! So while Ceretropic is going to be going through some big changes in the coming months, they are going to be changes for good.
Peptides have opened up a new frontier for effectiveness. I think everyone has been blown away at just how effective some of them are. That is why I had been devoting a lot of my time to them. However, we are going to have to start moving away from them for the time being. That does not mean I am not going to work on them. That is far from the situation. We are just going to be doing a lot of the development and research in the background, and really taking that side of things to a proper pharmaceutical research level.
The public side of Ceretropic is going to start shifting to novel natural compounds, new solutions, and improvements to existing compounds. It's going to be a lot more consumer-oriented, and be friendly for newcomers and veterans alike. The more research-based compounds are going to be on a separate site, with only approved accounts being allowed to purchase. This is going to prevent people new to the community from getting into substances they might not be prepared for or educated about, while still allowing the main goal of pushing the Nootropics space forward. With how much our space has grown, our customer base is very diverse now. We have everyone from university researchers, who are running scientific trials on compounds, to people just hearing about Nootropics. Making a clear separation between the different offerings is going to be good for everyone in the long run. As always, constructive criticism from the community is welcome. We want to make sure that things are done safely and for the benefit of everyone.
As far as new products are concerned, I have a lot of ideas. Obviously P21 and NA-Semax Amidate sprays are already scheduled for release. However, we have a ton of other new compounds that we will be working on, in tandem to the new compounds coming out on Nootropics Depot. My plan is to spend a few million dollars this year on new product development, with very aggressive release schedules. ND is having 2-4 new products come out every two weeks, with some weeks having even more. Ceretropic is going to to have a bit slower of a release schedule, but still have a ton of new things come out. New solution, new powders, new sprays, and custom stacks are all going to be coming out. On top of that, Nootropics Depot is coming out with a ton of encapsulated products, along with a whole line of stacks personally developed by me. So I am super excited about that. 2016 is going to be a good year. We might even be able to top 2015! (hopefully excluding the last quarter)